Obsidian Personal Planning Solutions’s AbbVie ABBV Stock Holding History

Obsidian Personal Planning Solutions’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$409K	Buy	1,877 +130	+7%	+$26.5K	0.14%	63
2025 Q2	$324K	Sell	1,747 -6	-0.3%	-$1.11K	0.13%	71
2025 Q1	$342K	Sell	1,753 -2	-0.1%	-$389	0.15%	59
2024 Q4	$323K	Sell	1,755 -40	-2%	-$7.35K	0.16%	61
2024 Q3	$366K	Sell	1,795 -3	-0.2%	-$560	0.19%	52
2024 Q2	$308K	Hold	1,798	–	–	0.19%	63
2024 Q1	$292K	Buy	1,798 +63	+4%	+$10.9K	0.19%	63
2023 Q4	$269K	Sell	1,735 -1	-0.1%	-$146	0.2%	59
2023 Q3	$259K	Sell	1,736 -1	-0.1%	-$147	0.22%	57
2023 Q2	$234K	Buy	+1,737	New	+$255K	0.29%	62

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Obsidian Personal Planning Solutions's ABBV Position: Q3 2025 in Review

Obsidian Personal Planning Solutions increased its AbbVie (ABBV) stake by 7.4% in Q3 2025, buying an estimated $26.5K and bringing the position to 1,877 shares worth $409K. The position accounts for 0.14% of the portfolio, ranked #63.

Obsidian Personal Planning Solutions first reported a position in ABBV in Q2 2023 and has held it in 10 quarters since. 3,905 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.

Obsidian Personal Planning Solutions held 1,877 shares of AbbVie worth $409K as of Q3 2025.
Obsidian Personal Planning Solutions bought 130 AbbVie shares in Q3 2025, an estimated $26.5K.
AbbVie made up 0.14% of Obsidian Personal Planning Solutions's portfolio in Q3 2025, its #63 holding.
Obsidian Personal Planning Solutions first reported a position in AbbVie in Q2 2023 and has held it in 10 quarters since.
3,905 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.

Based on Obsidian Personal Planning Solutions's 13F filing for Q3 2025, filed 13 Nov 2025.